Hannele Yki-Järvinen

Person

Latest publications

  1. Efficacy and safety of linagliptin as add-on therapy to basal insulin and metformin in people with Type 2 diabetes

    Duran-Garcia, S., Lee, J., Yki-Jarvinen, H., Rosenstock, J., Hehnke, U., Thiemann, S., Patel, S. & Woerle, H. -J. Jul 2016 In : Diabetic Medicine. 33, 7, p. 926-933 8 p.

    Publication: Contribution to journalA1 Refereed journal article

  2. Diagnosis of non-alcoholic fatty liver disease (NAFLD)

    Yki-Jarvinen, H. Jun 2016 In : Diabetologia. 59, 6, p. 1104-1111 8 p.

    Publication: Contribution to journalA2 Review in scientific journal

  3. Non-alcoholic fatty liver disease and risk of type 2 diabetes

    Lallukka, S. & Yki-Jarvinen, H. Jun 2016 In : Best Practice & Research. Clinical Endocrinology & Metabolism. 30, 3, p. 385-395 11 p.

    Publication: Contribution to journalA1 Refereed journal article

View all (182) »

Latest activities

  1. Subtypes of non-alcoholic fatty liver disease: Lessons from human studies

    Hannele Yki-Järvinen (Speaker: Presenter), 15 Jan 2015

    Activity: Conferences, workshops, courses, seminarsOrganisation and participation in conferences, workshops, courses, seminars

  2. 3U Partnership's 3rd Annual Conference Current Changes in Diabetes Research

    Hannele Yki-Järvinen (Speaker: Presenter), 23 Jan 2015

    Activity: Conferences, workshops, courses, seminarsOrganisation and participation in conferences, workshops, courses, seminars

  3. Invited lecture: Non-alcoholic fatty liver disease (NAFLD). A new challenge for the diabetologist

    Hannele Yki-Järvinen (Speaker: Presenter), 11 Feb 2015

    Activity: Conferences, workshops, courses, seminarsOrganisation and participation in conferences, workshops, courses, seminars

View all (350) »

Education

Lääketieteen tohtori

ID: 62216